Canadian Innovation During The COVID-19 Pandemic

Published date02 December 2020
Subject MatterPatents,Innovation,Biotechnology,Vaccinations,Patent Applications,Biopharmaceutical,Pharmaceutical Patents,Canadian Intellectual Property Office (CIPO),Canada,Research and Development,Pharmaceutical Industry,Coronavirus/COVID-19
AuthorColleen Spring Zimmerman,Catherine Hart
Law FirmInternational Lawyers Network

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT